Home » Stocks » ICUI

ICU Medical, Inc. (ICUI)

Stock Price: $207.27 USD 4.13 (2.03%)
Updated Jun 21, 2021 12:15 PM EDT - Market open
Market Cap 4.31B
Revenue (ttm) 1.26B
Net Income (ttm) 93.77M
Shares Out 21.15M
EPS (ttm) 4.33
PE Ratio 47.88
Forward PE 29.50
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $207.27
Previous Close $203.14
Change ($) 4.13
Change (%) 2.03%
Day's Open 204.11
Day's Range 202.48 - 207.83
Day's Volume 24,934
52-Week Range 170.57 - 227.07

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ICU Medical (ICUI) delivered earnings and revenue surprises of 5.88% and 4.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

SAN CLEMENTE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and crit...

1 month ago - GlobeNewsWire

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

As bond yields pop and the rotation out of tech into recovery plays continues, Q.ai's Artificial Intelligence has brought you today's top buys.

Other stocks mentioned: AFL, CAG, HRC, SJW
3 months ago - Forbes

SAN CLEMENTE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

3 months ago - GlobeNewsWire

SAN CLEMENTE, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

3 months ago - GlobeNewsWire

SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

5 months ago - GlobeNewsWire

This medical device company is a vital part of the backbone of hospital products utilized in the U.S. and around the world.

5 months ago - The Motley Fool

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

ICU Medical (ICUI) delivered earnings and revenue surprises of 48.44% and 13.53%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

SAN CLEMENTE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...

8 months ago - GlobeNewsWire

SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and ...

9 months ago - GlobeNewsWire

ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

SAN CLEMENTE, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and c...

10 months ago - GlobeNewsWire

SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ -- ICU Medical Inc.

10 months ago - PRNewsWire

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10 months ago - Zacks Investment Research

SAN CLEMENTE, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and c...

11 months ago - GlobeNewsWire

NEW YORK, June 2, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU" or "the Company") ...

1 year ago - PRNewsWire

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: EXPI, IIPR, PJT, ROCK
1 year ago - Zacks Investment Research

The best large-cap industries are electronic gaming, drugmakers, gold, packaged foods, and healthcare plans.

Other stocks mentioned: AKAM, AMZN, ATVI, BIIB, CNC, DXCM, EA ...
1 year ago - Seeking Alpha

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: AWR, EXPI, SFL, UTI
1 year ago - Zacks Investment Research

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ICU Medical (ICUI) delivered earnings and revenue surprises of 19.75% and 6.79%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

ICU Medical, Inc (ICUI) CEO Vivek Jain on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ICU Medical (ICUI) delivered earnings and revenue surprises of 1.85% and 6.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

SAN CLEMENTE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and ...

1 year ago - GlobeNewsWire

ICU Medical, Inc. (ICUI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

1 year ago - Zacks Investment Research

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ICU Medical (ICUI) delivered earnings and revenue surprises of -4.78% and 1.32%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

ICU Medical (ICUI) delivered earnings and revenue surprises of 18.35% and 4.13%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

ICU Medical (ICUI) could produce exceptional returns because of its solid growth attributes.

2 years ago - Zacks Investment Research

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana h... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Mar 31, 1992
CEO
Vivek Jain
Employees
7,900
Stock Exchange
NASDAQ
Ticker Symbol
ICUI
Full Company Profile

Financial Performance

In 2020, ICU Medical's revenue was $1.27 billion, an increase of 0.38% compared to the previous year's $1.27 billion. Earnings were $86.87 million, a decrease of -14.02%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for ICU Medical stock is "Buy." The 12-month stock price forecast is 240.33, which is an increase of 15.95% from the latest price.

Price Target
$240.33
(15.95% upside)
Analyst Consensus: Buy